Stocks
Neurocrine Biosciences (NBIX) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | 219.1 | 318.9 | 196.9 | 249.0 | 250.9 | 587.3 | |||
| Changes by years, y/y, % | +494% | +46% | -38% | +26% | +1% | +46.7% | |||
Neurocrine Biosciences. Operating Income, bln rub
Neurocrine Biosciences. Operating Income, changes, %
Neurocrine Biosciences. Operating Income, sum by quarters, bln rub
Neurocrine Biosciences (NBIX) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | 141.2 | 150.3 | 105.3 | 147.9 | 183.8 | 587.3 | ||
| Changes by years, y/y, % | +61% | +45% | -192% | +101% | +30% | |||
| Changes by quarters, q/q, % | +92% | +6% | -30% | +40% | +24% | |||
